Centric Wealth Management Increases Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Centric Wealth Management raised its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 4.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 8,609 shares of the company’s stock after acquiring an additional 351 shares during the period. Centric Wealth Management’s holdings in Procter & Gamble were worth $1,362,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in PG. Dfpg Investments LLC grew its position in shares of Procter & Gamble by 1.7% during the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock worth $3,680,000 after acquiring an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC raised its stake in Procter & Gamble by 6.3% during the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after acquiring an additional 260 shares during the last quarter. Herold Advisors Inc. lifted its position in Procter & Gamble by 2.2% during the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock worth $3,897,000 after acquiring an additional 581 shares during the period. Metis Global Partners LLC grew its stake in shares of Procter & Gamble by 15.7% in the 4th quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after purchasing an additional 15,599 shares during the last quarter. Finally, N.E.W. Advisory Services LLC increased its holdings in shares of Procter & Gamble by 14.6% in the third quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after purchasing an additional 12,016 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

NYSE PG traded down $0.66 during trading hours on Wednesday, reaching $165.10. The company’s stock had a trading volume of 2,462,324 shares, compared to its average volume of 6,845,249. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The company’s 50-day moving average is $160.23 and its two-hundred day moving average is $154.49. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $166.37. The stock has a market cap of $389.66 billion, a PE ratio of 27.06, a PEG ratio of 3.34 and a beta of 0.43.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same period last year, the firm posted $1.37 EPS. The firm’s revenue for the quarter was up .6% on a year-over-year basis. Analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is 65.69%.

Insider Buying and Selling at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 31,859 shares of Procter & Gamble stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the completion of the sale, the chief operating officer now directly owns 9,739 shares in the company, valued at $1,605,961.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, COO Shailesh Jejurikar sold 31,859 shares of Procter & Gamble stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the completion of the sale, the chief operating officer now directly owns 9,739 shares in the company, valued at $1,605,961.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The disclosure for this sale can be found here. In the last three months, insiders sold 118,724 shares of company stock worth $19,312,729. 0.17% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of analyst reports. UBS Group lifted their price objective on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Argus boosted their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Raymond James increased their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft lowered their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Finally, Jefferies Financial Group increased their target price on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $169.76.

View Our Latest Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.